PRODUCT TECH NOTE CARDIAC MAb PAIRS
PERFORMANCE SUMMARY
Anti-Troponin I
CAPTURE DETECTION APPLICATION LIMIT OF DETECTION
IDEAL APPLICATORS
BN1243 BN1244
CLIA
1.46 ng/mL
High-throughput clinical diagnostics
Correlation between Meridian antibodies (Cat. No. BN1243 and Cat. No. BN1244 ) in a CLIA assay and the Roche Elecsys ® Troponin I STAT (Cobas e411) using clinical samples. The assay showed a strong linear correlation ( R 2 = 0.94 ) across the tested Troponin I concentration range.
COMPARATIVE CORRELATION CLIA | Meridian & Roche
y = 0.8922x + 0.1828 R 2 = 0.94
Roche (ng/mL)
Anti-Human CRP hs
CAPTURE DETECTION APPLICATION LIMIT OF DETECTION
IDEAL APPLICATORS
1 CLIA
High-throughput clinical diagnostics Point-of-care, multiplex panels
0.001 µ g/mL
BN1246 BN1247
2 FIA
1 µ g/mL
1 COMPARATIVE CORRELATION CLIA | Meridian & Roche
2 COMPARATIVE CORRELATION FIA | Meridian & Roche
y = 0.9789x — 2.1199 R 2 = 0.96
y = 1.0301x — 0.0091 R 2 = 0.99
Roche (ng/mL)
Roche (mg/L)
[ 1 ] Correlation between Meridian antibodies (Cat. No. BN1246 and Cat. No. BN1247 ) in a CLIA assay and the Roche Elecsys ® CRP STAT (Cobas C702) using clinical samples. The assay showed a strong linear correlation ( R 2 = 0.96 ) across the tested CRP concentration range.
[ 2 ] Correlation between Meridian antibodies (Cat. No. BN1246 and Cat. No. BN1247 ) in a FIA assay and the Roche Elecsys ® CRP STAT (Cobas C702) using clinical samples. The assay showed a strong linear correlation ( R 2 = 0.99 ) across the tested CRP concentration range.
Powered by FlippingBook